Recent advances in IgG4-related kidney disease

Keyphrases

• Recent Advances 100%
• IgG4-related Kidney Disease 100%
• Differential Diagnosis 66%
• Early Withdrawal 66%
• Rituximab 33%
• Idiopathic multicentric Castleman Disease (iMCD) 33%
• Early Diagnosis 33%
• Treatment Strategy 33%
• Steroid Therapy 33%
• Maintenance Therapy 33%
• IgG4-related 33%
• Minimum Effective Dose 33%
• Hypocomplementemia 33%
• IgG4-related Tubulointerstitial Nephritis 33%
• Recurrent Disease 33%
• Diagnostic Approach 33%
• Kidney Lesions 33%
• Antineutrophil Cytoplasmic Antibody-associated Vasculitis 33%
• Glucocorticoid Toxicity 33%
• Immunoglobulin G4-related Kidney Disease 33%
• Emergent Treatment 33%
• Precise Diagnosis 33%
• Membranous Glomerulonephritis 33%
• Pyelitis 33%

Medicine and Dentistry

• Immunoglobulin G4 100%
• Nephropathy 100%
• Glucocorticoid 33%
• Differential Diagnosis 33%
• Disease 16%
• Interstitial Nephritis 16%
• Diagnosis 16%
• Angiofollicular Lymph Node Hyperplasia 16%
• Rituximab 16%
• Immunosuppressant 16%
• Recurrent Disease 16%
• Steroid Therapy 16%
• Kidney Injury 16%
• Maintenance Therapy 16%
• Hypocomplementemia 16%
• Pyelonephritis 16%
• ANCA Associated Vasculitis 16%
• Membranous Glomerulonephritis 16%